- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02099734
Germ Cell Tumor and Testicular Tumor DNA Registry
This study is being done to create a registry to help us learn more about germ cell tumors (GCT) and other testicular tumors. The registry will include people with these tumors and also relatives and unrelated people without these tumors. This study will help us learn more about the prevention, diagnosis, treatment and outcome of these tumors. Studying relatives of patients and people unrelated to patients with GCT and other testicular tumors will help us understand why some people get these tumors and why some people don't.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Zsofia Stadler, MD
- Phone Number: 646-888-4039
Study Contact Backup
- Name: Darren Feldman, MD
- Phone Number: 646-422-4491
Study Locations
-
-
New Jersey
-
Basking Ridge, New Jersey, United States
- Recruiting
- Memorial Sloan Kettering Basking Ridge
-
Contact:
- Darren Feldman, MD
- Phone Number: 646-422-4491
-
Middletown, New Jersey, United States, 07748
- Recruiting
- Memorial Sloan Kettering Monmouth
-
Contact:
- Darren Feldman, MD
- Phone Number: 646-422-4491
-
Montvale, New Jersey, United States, 07645
- Recruiting
- Memorial Sloan Kettering Bergen
-
Contact:
- Darren Feldman, MD
- Phone Number: 646-422-4491
-
-
New York
-
Cold Spring Harbor, New York, United States, 11724
- Not yet recruiting
- Cold Springs Harbor Laboratory (Specimen Analysis)
-
Contact:
- Richard McCombie, PhD
- Phone Number: 516-367-8800
-
Commack, New York, United States, 11725
- Recruiting
- Memorial Sloan Kettering Commack
-
Contact:
- Darren Feldman, MD
- Phone Number: 646-422-4491
-
Harrison, New York, United States, 10604
- Recruiting
- Memorial Sloan Kettering Westchester
-
Contact:
- Darren Feldman, MD
- Phone Number: 646-422-4491
-
New York, New York, United States, 10065
- Recruiting
- Memorial Sloan Kettering Cancer Center
-
Contact:
- Darren Feldman, MD
- Phone Number: 646-422-4491
-
Principal Investigator:
- Darren Feldman, MD
-
Uniondale, New York, United States, 11553
- Not yet recruiting
- Memorial Sloan Kettering Nassau
-
Contact:
- Darren Feldman, MD
- Phone Number: 646-422-4491
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
At MSKCC, the following outpatient clinics will be used to recruit GCT and testicular tumor cases and controls: Urology (Department of Surgery), Gynecologic Oncology (Department of Surgery) Clinical Genetics, Genitourinary Oncology (Department of Medicine), and Gynecologic Medical Oncology (Department of Medicine).
Description
Inclusion Criteria:
Case Cohort
- Must be ≥ 18 years of age AND
- Must be an English-speaker AND
- Must have a diagnosis or suspicion of germ cell tumor and/or a testicular mass
Family Member Cohort
- Must be ≥ 18 years of age AND
- Must be an English-speaker AND
- Must be a blood relative of the proband. Family members of probands are eligible. These individuals need not have a diagnosis of GCT-TT, as they will be used for segregation analysis of suspected variants found in the proband.
Control Cohort
- Must be ≥ 18 years of age AND
- Must be an English-speaker AND
- Must not have a personal history of cancer, with the exception of non-melanoma skin cancer, AND
- Must not have a family history of germ cell tumor or testicular tumor AND
- Must not be a blood relative of controls enrolled in this study
Exclusion Criteria:
Study Plan
How is the study designed?
Design Details
- Observational Models: OTHER
- Time Perspectives: PROSPECTIVE
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
A: suspicion of germ cell tumor and/or a testicular mass
patients with testicular GCTs and non-GCT testicular tumors, extragonadal male GCTs, and female GCTs, |
A sample of blood or saliva will be obtained for DNA extraction. Approximately 2-4 tubes of blood will be collected or one tablespoon of saliva. If a participant has already provided a DNA sample for another MSKCC IRB approved protocol, they may not need to provide an additional sample. |
|
B: family members of Group A
relatives of patients with GCTs or testicular tumors |
A sample of blood or saliva will be obtained for DNA extraction. Approximately 2-4 tubes of blood will be collected or one tablespoon of saliva. If a participant has already provided a DNA sample for another MSKCC IRB approved protocol, they may not need to provide an additional sample. |
|
C: healthy controls unrelated to Group A or B
healthy controls who are unrelated to Groups A or B and do not have a personal history of cancer nor a family history of GCT or non-GCT testicular tumors |
A sample of blood or saliva will be obtained for DNA extraction. Approximately 2-4 tubes of blood will be collected or one tablespoon of saliva. If a participant has already provided a DNA sample for another MSKCC IRB approved protocol, they may not need to provide an additional sample. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
creation of a Germ Cell Tumor and testicular tumor registry
Time Frame: 5 years
|
We will collect clinical data including diagnosis date, pathology, family history, and risk factors in patients with GCT-TT. |
5 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Darren Feldman, MD, Memorial Sloan Kettering Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Genital Diseases
- Endocrine System Diseases
- Genital Neoplasms, Male
- Urogenital Neoplasms
- Neoplasms by Site
- Neoplasms
- Genital Diseases, Male
- Male Urogenital Diseases
- Neoplasms by Histologic Type
- Endocrine Gland Neoplasms
- Gonadal Disorders
- Testicular Diseases
- Neoplasms, Germ Cell and Embryonal
- Testicular Neoplasms
- Health Care Quality, Access, and Evaluation
- Investigative Techniques
- Epidemiologic Methods
- Data Collection
- Health Care Evaluation Mechanisms
- Quality of Health Care
- Public Health
- Environment and Public Health
- Surveys and Questionnaires
Other Study ID Numbers
- 14-016
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.